Hanmi Pharmaceutical Dividend yield

Hanmi Pharmaceutical is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Hanmi Pharmaceutical is a company from Korea, and his stocks are publicly traded.

Hanmi Pharmaceutical stock dividend

Hanmi Pharmaceutical paid a total dividend of 6,508 million KRW last year, for a market value of 3,828,500 millions (Market Cap 2,226,215 millions). Hanmi Pharmaceutical dividend per share is 500.65 KRW, and his stock market price 294,500.00 KRW.

According to the chart below, where dividend yield is displayed, Hanmi Pharmaceutical has a dividend yield of 0.17%, lower than the amount offered by both the market average and companies from Korea. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Hanmi Pharmaceutical stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the highest Korea dividend stocks list.

Hanmi Pharmaceutical Dividend Payout

About the ability of Hanmi Pharmaceutical to maintain his current dividend of KRW 500.65 per share, an amount that accounts for 0.17%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Hanmi Pharmaceutical payout on ernings is currently 6.55%, which is lower than the market average and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures lead us to believe that there is confidence that Hanmi Pharmaceuticalcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Hanmi Pharmaceutical is KRW 13,030.97 per share, which is higher than the dividend per share paid by the company of KRW 500.65, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Hanmi Pharmaceutical, compared againt world market average, Korea companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Hanmi Pharmaceutical Dividend History

Below you will find a table with the historical evolution of Hanmi Pharmaceutical's dividend stock, both in percentage and in KRW, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	KRW	Paypout	Shares*
Present	0.17%	500.65	6.55%	13
2022	0.16%	476.80	7.63%	13
2021	0.17%	469.20	0.00%	12
2020	0.13%	476.45	9.67%	12
2019	0.16%	474.40	0.00%	12
2018	0.10%	464.00	8.24%	12
2017	0.31%	1,810.40	0.00%	11
2016	0.53%	1,953.05	11.45%	10
2015	0.00%	0.00	0.00%	10

*In millions

Then you can see the evolution of Hanmi Pharmaceutical dividend stock, and compare it with the average of Korea stocks and that of the Pharmaceuticals and Biotechnology stocks.

Hanmi Pharmaceutical Stock performance

Finally, last moth Hanmi Pharmaceutical showed a return of 10.50% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -2.50% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Korea and Pharmaceuticals and Biotechnology firms.